Research Announcements

NPOD Project Leader RFA 2019

Deadline:  September 15, 2019
Link to RFA

The Nebraska Center for the Prevention of Obesity Diseases through Dietary Molecules (NPOD) seeks to identify a new cohort of project leaders, effective June 1, 2020. The NPOD is funded by a Center for Biomedical Research Excellence Phase II grant (award number P20GM104320) from the NIH, and builds research infrastructure in obesity research and nutrient signaling at UNL and UNMC.

Both pre-tenure (junior investigators) and established investigators are invited to apply. Established investigators are expected to have a track record of competitive external funding.

Project leader funding is the highest level of support provided by NPOD. Pre-tenure project leaders will be paired with mentors to guide them to success, defined as securing independent external funding. Established investigators will be matched with mentors if so desired.


  • UNL or UNMC faculty at all ranks are eligible to apply
  • The proposed research must focus on obesity-related metabolic diseases, or signaling by nutrients or bioactive food compounds
  • Project leaders will devote six person-months for junior investigators and three person-months for established investigators to their NPOD project
  • Previous project leaders are not eligible to apply

Time line:

  • Letters of intent must be received by NPOD no later than September 15, 2019, 5:00 p.m. CDST (see Instructions, below)
  • Select applicants will be invited in late September to submit a full proposal
  • Full proposals (NIH R01 style) will be due no later than November 15 2019, 5:00 p.m. CST
  • NPOD reviewers will review applications throughout November using NIH review criteria and make recommendations for funding to the center’s external advisory committee (EAC)
  • NPOD’s EAC will review and approve/disapprove proposals (December of 2019)
  • NIH will review for compliance and approve/disapprove proposals for funding in January or February of 2020
  • Funding will start June 1, 2020


  • Letters of intent must be received by NPOD no later than September 15, 2019, 5:00 p.m. CDST
  • Letters must provide the following information:

~        Cover letter with contact information (no more than one page)

~        Brief outline of the proposed (one page, Arial 11, 0.5” margins): at a minimum state the central hypothesis, specific aims, a short description of methods, and plans for future funding. Note that NPOD will provide funding of up to $150,000 per year for up to three years (no F&A, no equipment); the proposed research must be appropriate for the level of funding.

~        NIH-style biosketch (no more than five pages)

  • Submit letters of intent to Dr. Janos Zempleni and/or Ms. Sarah Gibson (see below for contact information)

Next steps:

  • NPOD will contact select applicants with additional information

Additional information:

  • NPOD project leaders will become members of the center (see for benefits)
  • Project leaders are expected to participate in monthly NPOD meeting, spring retreats, fall research symposia, and provide written progress reports in preparation for annual renewals with NIH (typically in February/March), and oral reports to the EAC (typically in September)

Contact information:

PCORI Announces Cycle 3 2019 Research Areas of Interest

Broad PCORI Funding Announcements — Cycle 3 2019
(for Addressing Disparities, Assessment of Options, Communication and Dissemination Research, Improving Healthcare Systems)

This PCORI Funding Announcement will open on Tuesday, September 3, 2019.

The Broad PCORI Funding Announcements (PFAs) seek investigator-initiated applications for patient-centered comparative clinical effectiveness research (CER) projects aligned with our priority areas for research. This PFA covers the following four priority areas: Addressing Disparities; Assessment of Prevention, Diagnosis, and Treatment Options; Communication and Dissemination Research, and Improving Health Systems. These broad areas encompass the patient-centered comparative CER we support.

For this cycle, PCORI has updated its Research Areas of Interest to include:

  • Dosing of anti-neoplastic agents in adults
  • Genetic sequencing to guide cancer treatment
  • Peripheral artery disease
  • Suicide prevention

The goal of calling these out is to encourage applications on these topics, not to limit applications to these topics.

Applications should address needs of patients, caregivers, clinicians, and other healthcare stakeholders in making personalized clinical decisions across a wide range of conditions, populations, and treatments. Note: In general, PCORI will not cover costs for interventions that are being compared in the proposed study.

Our National Priorities for Research and Research Agenda is a framework to guide our funding of comparative clinical effectiveness research that will give patients and those who care for them the ability to make better-informed health decisions. The framework was developed by workgroups of our Board of Governors, members of our Methodology Committee, and staff.

Reminder: The primary institution’s Administrative Official must review, authorize, and submit the full application by 5 pm ET on January 14, 2020.

Key Information can be found on the PCORI website.